We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Two Lidoderm Class Action Deals Worth $271M Get Final OK

Law360, San Francisco (September 12, 2018, 10:54 PM EDT) -- A California federal judge on Wednesday approved “excellent” settlements ending claims that Teikoku, Endo and Actavis violated antitrust laws by stalling the release of a generic form of the Lidoderm pain...
To view the full article, register now.